Adult Solid Neoplasm (1)

Childhood Solid Neoplasm (1)

Recurrent Childhood Central Nervous System Neoplasm (1)

Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (1)

Recurrent Malignant Solid Neoplasm (1)

Refractory Central Nervous System Neoplasm (1)

Completed (1)

phase 1/phase 2 (1)

National Cancer Institute (NCI) (1)

laboratory biomarker analysis (1)

pharmacological study (1)

talazoparib (1)

temozolomide (1)

drug (1)

other (1)

NIH (1)

Interventional (1)

refractory central nervous system neoplasm

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Mar 1, 2021